A Single-Arm, Open-Label Phase I/II Clinical Trial of Intraperitoneal Perfusion of SK-NK Cell Injection for the Treatment of Advanced Ovarian Cancer Patients With Massive Ascites
Latest Information Update: 19 Mar 2026
At a glance
- Drugs Super Kill Natural Killer Cell therapy Cells First Biotechnology (Primary)
- Indications Ovarian cancer
- Focus Adverse reactions
Most Recent Events
- 05 Mar 2026 New trial record